Can a common arthritis drug stop hand joint damage?
NCT ID NCT07501507
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether methotrexate, a drug used for other types of arthritis, can slow joint damage in people with painful hand osteoarthritis that hasn't gotten better with standard treatments. About 170 adults with erosive hand osteoarthritis will receive either methotrexate or a placebo for one year. The main goal is to see if the drug reduces worsening of joint damage on X-rays.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EROSIVE HAND OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Nice
Nice, 06000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.